SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-351898
Filing Date
2011-12-23
Accepted
2011-12-23 15:36:10
Documents
4
Period of Report
2011-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d273547d8k.htm 8-K 20977
2 MERGER TERMINATION AGREEMENT d273547dex22.htm EX-2.2 4293
3 PRESS RELEASE d273547dex991.htm EX-99.1 2579
4 GRAPHIC g273547g24q83.jpg GRAPHIC 13239
  Complete submission text file 0001193125-11-351898.txt   47571
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 530 SEATTLE WA 98119-4114
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 111280317
SIC: 2834 Pharmaceutical Preparations